Psilocybin
Psyched: Jada Pinkett-Smith’s Ayahuasca Journey, RIP Dr. Roland Griffiths, Congressional VA Hearings Halted
Jada Pinkett Smith Opens Up About Ayahuasca: It Helped Her Overcome Depression And Suicidal Thoughts
Jada Pinkett Smith has joined the growing number of…
Jada Pinkett Smith Opens Up About Ayahuasca: It Helped Her Overcome Depression And Suicidal Thoughts
Jada Pinkett Smith has joined the growing number of Hollywood celebs who are sharing difficult mental health issues and the fact that psychedelic substances are helping them deal with them. “Ayahuasca helped me. It gave me a new, intimate relationship with myself that I had never had before,” Pinkett Smith said. The actress told People that her experience helped her expel suicidal ideations, which she said began when turned 40 but then “completely went away” after the ayahuasca experience. Read more HERE.Esteemed Psychedelic Researcher And Pioneer Roland Griffiths Dies At Age 77
Dr. Roland Griffiths was a leading psychedelics neuroscientist and esteemed psychopharmacologist at Johns Hopkins University. He's been described as the man who brought psilocybin back into the field of medical research for the first time in decades by conducting his first clinical trial with psilocybin in 1999. Continue reading HERE.Congress Halts Hearing On Psychedelics & Veterans: House Speaker Drama Continues
A hearing of the House VA’s subcommittee on Health around the use of psychedelic-assisted therapies for mental health disorders originally scheduled for Thursday was postponed following the ongoing failed attempt to elect a House speaker. The “Emerging Therapies: Breakthroughs in the Battle Against Suicide?” hearing would be the first-ever to reunite federal lawmakers on the specific discussion of how entheogenic substances could help address the veteran suicide epidemic. Continue reading HERE.Harvard's New Psychedelics Research Program Backed By Former Tesla Director's $16M Donation
Harvard University will create a Study of Psychedelics in Society and Culture backed ... Full story available on Benzinga.com ayahuasca psilocybin psychedelic depression psychedelics deal psyched research-
Psychedelics1 week ago
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study of Bucillamine to Treat Long COVID
-
Psychedelics1 week ago
Algernon NeuroScience and the Centre for Human Drug Research to Present DMT Phase 1 Stroke Clinical Data at the Interdisciplinary Conference on Psychedelic Research June 6 – 8th, 2024
-
Law & Regulation1 week ago
Tryp Therapeutics merger with Exopharm approved by shareholders
-
Psilocybin1 week ago
Passover Perspectives: Psychedelics, Moses, and the Burning Bush
-
Psychedelics1 week ago
atai Life Sciences Announces Dosing of First Patient in Part 2 of Beckley Psytech’s Phase 2a Study Exploring BPL-003 Adjunctive to SSRIs in Patients with Treatment Resistant Depression
-
Psychedelics1 week ago
Silo Pharma Announces Positive Results for Intranasal PTSD Treatment
-
Psilocybin1 week ago
Psilocybin and Meditation: Unlocking the Potential for Enhancing Insightfulness
-
Psychedelics1 week ago
Silo Pharma Announces Positive Results for Intranasal PTSD Treatment